NEW ORLEANS – An estate executor has filed suit against several pharmaceutical companies alleging a drug cause his mother's death.
Thomas Vecchiarelli, as a surviving son of Belinda Bradley-Antonelli, filed a complaint on May 25 in the U.S. District Court for the Eastern District of Louisiana against Janssen Research & Development LLC, Janssen Ortho LLC, Janssen Pharmaceuticals Inc., Bayer Healthcare Pharmaceuticals Inc., et al. alleging strict liability, manufacturing defect and other counts.
According to the complaint, the plaintiff alleges that decedent Bradley-Antonelli ingested Xarelto from approximately June 30, 2014, to July 6, 2014. As a result of suing Xarelto, the suit states she suffered severe internal bleeding and ultimately died on July 6, 2014. The plaintiff holds the defendants responsible because the defendants allegedly designed, researched, manufactured, tested, advertised, promoted, marketed, distributed and sold Xarelto; failed to properly investigate, research, study and define the safety of the drug's profile; failed to adequately test it or provide adequate warnings; failed to disclose the need for dose adjustments; and failed to provide adequate instructions on the drug's use.
The plaintiff requests a trial by jury and seeks compensatory damages in excess of the jurisdictional amount, prejudgment and post-judgment interest, reasonable attorneys’ fees, costs of these proceedings and such other and further relief as the court deems just and proper. He is represented by J. Christopher Elliott of Bachus & Schanker LLC in Denver, Colorado.
U.S. District Court for the Eastern District of Louisiana Case number 2:16-cv-07050